Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors

INTRODUCTION: Oral antidiabetes medications, including dipeptidyl peptidase-4 inhibitors (DPP-4is) saxagliptin and sitagliptin, are used for the treatment of type 2 diabetes (T2D). The study objective was to compare all-cause and diabetes-related costs following initiation of saxagliptin or sitaglip...

Descripción completa

Detalles Bibliográficos
Autores principales: Farr, Amanda M., Sheehan, John J., Brouillette, Matthew, Smith, David M., Johnston, Stephen S., Kalsekar, Iftekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735222/
https://www.ncbi.nlm.nih.gov/pubmed/26724938
http://dx.doi.org/10.1007/s12325-015-0277-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735222/
https://www.ncbi.nlm.nih.gov/pubmed/26724938
http://dx.doi.org/10.1007/s12325-015-0277-2

Ejemplares similares